New Genedrive® system readied for Antibiotic Induced Hearing Loss launch
Genedrive PLC (GDR.L) New Genedrive system readied for AIHL launch
Genedrive PLC (GDR.L) Genedrive® COVID-19 Point of Care device update
genedrive plc (AIM: GDR), the near-patient molecular diagnostics company, provides an update on the development of its Genedrive® COV19-ID Kit, a rapid Point of Care (PoC) molecular test for SARS-CoV-2
